[Differential dignosis: „primary“ or secondary diabetes - should Cushing´s syndrome be routinely screened in the patients with type 2 diabetes mellitus?]

Vnitr Lek. 2021 Summer;67(E-3):8-10.
[Article in Czech]

Abstract

Cushing´s syndrome is a rare disease with the population prevalence about 40 patients per 1 million inhabitants, the number among patients with diabetes mellitus (DM) is probably higher. The screening of CS among the DM patients showed the prevalence between 0-2.9% in the groups of outpatients and 2-2.9% among the patients admitted to the hospital at the time of randomization. The routine screening of CS among patients with type 2 DM is not recommended at the moment. Nevertheless, the possibility of CS should be taken into the account mainly in patients with hypertension, obesity, microvascular complications, bad level of metabolic control or high insulin doses, especially, if more of these features are present. A hormonal profile of patients with adrenal incidentaloma should be evaluated.

Keywords: Cushing´s syndrom; Cushing’s syndrome; adrenal incidentaloma; cardiovascular disease; diabetes mellitus; screning.

MeSH terms

  • Adrenal Gland Neoplasms*
  • Cushing Syndrome*
  • Diabetes Mellitus, Type 2*
  • Humans
  • Hydrocortisone
  • Mass Screening

Substances

  • Hydrocortisone